IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-64712-4.html
   My bibliography  Save this article

Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer

Author

Listed:
  • Gesa Mittmann

    (German Cancer Research Center (DKFZ)
    Heidelberg University)

  • Sara Laiouar-Pedari

    (German Cancer Research Center (DKFZ))

  • Hendrik A. Mehrtens

    (German Cancer Research Center (DKFZ))

  • Sarah Haggenmüller

    (German Cancer Research Center (DKFZ))

  • Tabea-Clara Bucher

    (German Cancer Research Center (DKFZ))

  • Tirtha Chanda

    (German Cancer Research Center (DKFZ)
    Heidelberg University)

  • Nadine T. Gaisa

    (RWTH Aachen University
    University of Ulm)

  • Mathias Wagner

    (Homburg Saar Campus)

  • Gilbert Georg Klamminger

    (Homburg Saar Campus)

  • Tilman T. Rau

    (Heinrich-Heine-University and University Hospital Düsseldorf)

  • Christina Neppl

    (Heinrich-Heine-University and University Hospital Düsseldorf)

  • Eva Maria Compérat

    (Medical University of Vienna)

  • Andreas Gocht

    (University Hospital Schleswig-Holstein)

  • Monika Haemmerle

    (Martin Luther University Halle-Wittenberg)

  • Niels J. Rupp

    (University Hospital Zurich
    University of Zurich)

  • Jula Westhoff

    (Städtisches Klinikum Karlsruhe)

  • Irene Krücken

    (Klinikum Bremen Mitte
    PathoNext GmbH)

  • Maximilian Seidl

    (Heinrich-Heine-University and University Hospital Düsseldorf)

  • Christian M. Schürch

    (University Hospital and Comprehensive Cancer Center Tübingen
    University of Tübingen)

  • Marcus Bauer

    (Martin Luther University Halle-Wittenberg)

  • Wiebke Solass

    (University Bern)

  • Yu Chun Tam

    (Ruhr University Bochum)

  • Florian Weber

    (University of Regensburg)

  • Rainer Grobholz

    (University of Zurich
    Cantonal Hospital Aarau)

  • Jaroslaw Augustyniak

    (Laborteam Pathology)

  • Thomas Kalinski

    (University Hospital Brandenburg an der Havel)

  • Christian Hörner

    (University of Heidelberg)

  • Kirsten D. Mertz

    (University Hospital Basel
    University of Basel)

  • Constanze Döring

    (Zweigpraxis Zwickau)

  • Andreas Erbersdobler

    (University Medicine Rostock)

  • Gabriele Deubler

    (Kreiskliniken Reutlingen)

  • Felix Bremmer

    (University Medical Center Goettingen)

  • Ulrich Sommer

    (University Hospital of Dresden)

  • Michael Brodhun

    (HELIOS Klinikum Erfurt)

  • Jon Griffin

    (University of Sheffield)

  • Maria Sarah L. Lenon

    (University of Santo Tomas Hospital
    National Kidney and Transplant Institute)

  • Kiril Trpkov

    (Rockyview General Hospital)

  • Liang Cheng

    (and Brown University Health)

  • Fei Chen

    (NYU Langone Health)

  • Angelique Levi

    (Yale University School of Medicine)

  • Guoping Cai

    (Yale University School of Medicine)

  • Tri Q. Nguyen

    (University Medical Centre Utrecht)

  • Ali Amin

    (Warren Alpert Medical School of Brown University)

  • Alessia Cimadamore

    (University of Udine)

  • Ahmed Shabaik

    (UC San Diego School of Medicine)

  • Varsha Manucha

    (University of Mississippi Medical Center)

  • Nazeel Ahmad

    (Department of Pathology & Cell Biology and James A. Haley Veterans’ Hospital)

  • Nidia Messias

    (Washington University in St. Louis)

  • Francesca Sanguedolce

    (University of Foggia)

  • Diana Taheri

    (Isfahan University of Medical Sciences
    Tehran University of Medical Sciences)

  • Ezra Baraban

    (Johns Hopkins University)

  • Liwei Jia

    (University of Texas Southwestern Medical Center)

  • Rajal B. Shah

    (University of Texas Southwestern Medical Center)

  • Farshid Siadat

    (Rockyview General Hospital)

  • Nicole Swarbrick

    (PathWest Laboratory Medicine WA
    UWA Medical School)

  • Kyung Park

    (NYU Langone Health)

  • Oudai Hassan

    (Henry Ford Health System)

  • Siamak Sakhaie

    (Dorevitch Pathology)

  • Michelle R. Downes

    (Sunnybrook Health Sciences Centre)

  • Hiroshi Miyamoto

    (University of Rochester Medical Center)

  • Sean R. Williamson

    (Cleveland Clinic)

  • Tim Holland-Letz

    (German Cancer Research Center(DKFZ))

  • Christoph Wies

    (German Cancer Research Center (DKFZ)
    Heidelberg University)

  • Carolin V. Schneider

    (RWTH University of Aachen)

  • Jakob Nikolas Kather

    (TUD Dresden University of Technology
    TUD Dresden University of Technology
    University Hospital Heidelberg
    University of Leeds)

  • Yuri Tolkach

    (University Hospital Cologne
    University of Cologne)

  • Titus J. Brinker

    (German Cancer Research Center (DKFZ))

Abstract

The aggressiveness of prostate cancer is primarily assessed from histopathological data using the Gleason scoring system. Conventional artificial intelligence (AI) approaches can predict Gleason scores, but often lack explainability, which may limit clinical acceptance. Here, we present an alternative, inherently explainable AI that circumvents the need for post-hoc explainability methods. The model was trained on 1,015 tissue microarray core images, annotated with detailed pattern descriptions by 54 international pathologists following standardized guidelines. It uses pathologist-defined terminology and was trained using soft labels to capture data uncertainty. This approach enables robust Gleason pattern segmentation despite high interobserver variability. The model achieved comparable or superior performance to direct Gleason pattern segmentation (Dice score: $${0.713}_{\pm 0.003}$$ 0.713 ± 0.003 vs. $${0.691}_{\pm 0.010}$$ 0.691 ± 0.010 ) while providing interpretable outputs. We release this dataset to encourage further research on segmentation in medical tasks with high subjectivity and to deepen insights into pathologists’ reasoning.

Suggested Citation

  • Gesa Mittmann & Sara Laiouar-Pedari & Hendrik A. Mehrtens & Sarah Haggenmüller & Tabea-Clara Bucher & Tirtha Chanda & Nadine T. Gaisa & Mathias Wagner & Gilbert Georg Klamminger & Tilman T. Rau & Chri, 2025. "Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
  • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64712-4
    DOI: 10.1038/s41467-025-64712-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-64712-4
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-025-64712-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64712-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.